Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
Life Sci Alliance. 2020 Apr 28;3(6). doi: 10.26508/lsa.202000735. Print 2020 Jun.
Caspase-1 drives a lytic inflammatory cell death named pyroptosis by cleaving the pore-forming cell death executor gasdermin-D (GSDMD). deficiency, however, only delays cell lysis, indicating that caspase-1 controls alternative cell death pathways. Here, we show that in the absence of GSDMD, caspase-1 activates apoptotic initiator and executioner caspases and triggers a rapid progression into secondary necrosis. GSDMD-independent cell death required direct caspase-1-driven truncation of Bid and generation of caspase-3 p19/p12 by either caspase-8 or caspase-9. tBid-induced mitochondrial outer membrane permeabilization was also required to drive SMAC release and relieve inhibitor of apoptosis protein inhibition of caspase-3, thereby allowing caspase-3 auto-processing to the fully active p17/p12 form. Our data reveal that cell lysis in inflammasome-activated -deficient cells is caused by a synergistic effect of rapid caspase-1-driven activation of initiator caspases-8/-9 and Bid cleavage, resulting in an unusually fast activation of caspase-3 and immediate transition into secondary necrosis. This pathway might be advantageous for the host in counteracting pathogen-induced inhibition of GSDMD but also has implications for the use of GSDMD inhibitors in immune therapies for caspase-1-dependent inflammatory disease.
Caspase-1 通过切割成孔细胞死亡执行器 gasdermin-D(GSDMD)驱动一种称为细胞焦亡的溶细胞炎症性细胞死亡。然而,缺陷仅延迟细胞裂解,表明 caspase-1 控制替代细胞死亡途径。在这里,我们表明在没有 GSDMD 的情况下,caspase-1 激活凋亡起始和执行 caspase 并引发快速进入继发性坏死。GSDMD 非依赖性细胞死亡需要直接 caspase-1 驱动的 Bid 截断和 caspase-8 或 caspase-9 产生 caspase-3 p19/p12。tBid 诱导的线粒体外膜通透性也是驱动 SMAC 释放和解除凋亡蛋白抑制 caspase-3 所必需的,从而允许 caspase-3 自身加工成全活性 p17/p12 形式。我们的数据表明,炎性体激活的细胞在 caspase-1 缺陷细胞中的裂解是由快速 caspase-1 驱动的起始 caspase-8/-9 的激活和 Bid 切割的协同作用引起的,导致 caspase-3 的异常快速激活并立即过渡到继发性坏死。该途径可能有利于宿主对抗病原体诱导的 GSDMD 抑制,但也对 GSDMD 抑制剂在 caspase-1 依赖性炎症性疾病的免疫治疗中的应用具有影响。